Independent
Tenure on this board
5.0 yrs
5 nominees · 4 ballot items.
Four proposals: (1) Elect five directors for one-year terms; (2) Advisory vote to approve named executive officer compensation (“say-on-pay”); (3) Ratify appointment of KPMG LLP as independent registered public accounting firm; (4) Advisory vote on the frequency (1, 2, or 3 years) of future advisory votes on executive compensation.
Elect the five nominees named in the proxy statement (Brian Davis, Vimal Kavuru, Prashant Kohli, George Kottayil and Edward Neugeboren) to the Board for one-year terms expiring at the 2027 Annual Meeting.
Non-binding, advisory proposal asking stockholders to approve, on an advisory basis, the compensation of the named executive officers as disclosed in the proxy statement (the 'say-on-pay' vote).
This management-sponsored, non-binding 'say-on-pay' proposal asks shareholders to approve the disclosed compensation of the company's named executive officers. Management frames the program as designed to attract, motivate and retain executives, align pay with shareholder interests, and follow a pay-for-performance philosophy; the Compensation Committee regularly reviews the program and considers market practices. The Board emphasizes that the vote is advisory and not binding, but that the Compensation Committee will take the voting outcome into account when setting future compensation. The proxy statement identifies corporate objectives for FY2026 (including NDA submission and FDA review support for GTx-104) that drove annual bonuses and equity awards, illustrating the company's link between pay and achievement of specific operational and regulatory milestones. The Board recommends a 'FOR' vote, citing alignment of compensation with shareholder interests, retention needs for key personnel, and oversight by an independent Compensation Committee supported by an independent compensation consultant. Risks include the advisory nature of the vote (no binding effect), potential short-term focus if shareholders emphasize annual outcomes, and the fact that some compensation elements (e.g., multi-year equity) are structured to deliver value over time, which may not be fully reflected in a single-year advisory vote. The company’s governance context — an independent board chair, majority-independent board, Compensation Committee oversight, and documented compensation consultant engagement — strengthens management’s case but does not eliminate shareholder scrutiny around realized pay versus performance. Institutional investors typically evaluate say-on-pay in light of both disclosed target compensation and realized pay; given material events (NDA submission/ FDA review) that influenced FY2026 payouts, analysts should weigh whether realized compensation reasonably reflects those achievements and long-term value creation. Overall, while the Board seeks shareholder endorsement to validate its compensation program design, investors will consider both the company’s rationale and historical pay-for-performance metrics when deciding whether to support the advisory approval.
Ratify the Audit Committee's appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2027.
Non-binding, advisory proposal asking stockholders to indicate whether the company should hold future advisory votes on executive compensation every 1, 2, or 3 years (or abstain); the Board recommends '1 YEAR.
This management-sponsored, non-binding frequency proposal asks shareholders to state whether future 'say-on-pay' votes should occur every one, two, or three years (or to abstain). Management emphasizes Exchange Act requirements that mandate holding such a frequency vote at least once every six years and frames the choice as a governance preference rather than a substantive change to compensation policy. The Board recommends an annual ('1 YEAR') frequency, arguing that annual disclosure cycles and the desire for more direct and immediate shareholder feedback justify yearly advisory votes. The Board also cautions that because advisory votes occur after the start of the compensation year and compensation elements are often multi-year and integrated, a vote selecting a different frequency may not meaningfully change near-term compensation outcomes. From an investor governance perspective, choosing a longer frequency could reduce administrative costs and avoid repetitious votes, but it would also lessen the cadence of shareholder input on pay; conversely, annual votes increase engagement and signal to management that pay decisions are under continual shareholder scrutiny. The Board’s recommendation is supported by its view that annual votes align with annual disclosures and facilitate timely feedback; however, shareholders should weigh whether annual advisory votes yield incremental governance benefits versus the administrative burden and potential for short-termism. Given the advisory nature of the vote, the Board retains discretion to set frequency despite the outcome; thus, investors should anticipate that the Board will consider the vote result as guidance rather than a binding mandate. Analysts evaluating this proposal should consider the company’s recent governance practices, the independence of its Compensation Committee, and how responsive management has historically been to advisory votes when assessing whether to support the Board’s recommendation.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Cerity Partners LLC | 4.04% | 849,055 | $2M |
| 2 | Eversept Partners, LP | 3.67% | 772,900 | $2M |
| 3 | BANK OF AMERICA CORP /DE/ | 2.35% | 494,698 | $1M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 1.96% | 411,714 | $935K |
| 5 | CITADEL ADVISORS LLC | 1.61% | 338,750 | $769K |
| 6 | Stonepine Capital Management, LLC | 1.40% | 294,550 | $62K |
| 7 | CANTOR FITZGERALD, L. P. | 0.95% | 200,000 | $454K |
| 8 | Maven Securities LTD | 0.95% | 200,000 | $454K |
| 9 | TWO SIGMA INVESTMENTS, LP | 0.46% | 96,890 | $220K |
| 10 | XTX Topco Ltd | 0.34% | 71,668 | $163K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.